Form 4 for TXMD TherapeuticsMD, Inc.
Accepted 2023-04-14 00:00:00 ET · period of report 2023-04-12 · accession 0001209191-23-024386 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-04-14 | 2023-04-12 | TXMD | Donegan Michael C | Prin. Fin, Acctg. Off | M - OptEx | $0.00 | +50.0K | 61.9K | +422% | $0 |
| D | 2023-04-14 | 2023-04-12 | TXMD | Donegan Michael C | Prin. Fin, Acctg. Off | M - OptEx | $0.00 | -50.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-04-12 | M | A | 50,000 | $0.00 | 61,853 | D | — | — | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of issuer common stock upon settlement. On April 12, 2023, the reporting person received 50,000 shares of issuer common stock in settlement of restricted stock units (RSUs). |
| 2 | Derivative | Restricted Stock Units | 2023-04-12 | M | D | 50,000 | $0.00 | 0 | D | $0.00 · — to — | 50,000 Common Stock | (F1) Each restricted stock unit ("RSU") represents a contingent right to receive one share of issuer common stock upon settlement. On April 12, 2023, the reporting person received 50,000 shares of issuer common stock in settlement of restricted stock units (RSUs). (F2) Each restricted stock unit (RSU) represents a contingent right to receive one share of common stock of the issuer. The RSUs vested in full on March 31, 2023. |